Shilanski & Associates Inc. Buys Shares of 13,555 Cardinal Health, Inc. $CAH

Shilanski & Associates Inc. purchased a new position in Cardinal Health, Inc. (NYSE:CAHFree Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 13,555 shares of the company’s stock, valued at approximately $2,128,000.

Several other hedge funds also recently modified their holdings of CAH. Norges Bank bought a new position in Cardinal Health during the second quarter worth $584,420,000. Zurich Insurance Group Ltd FI grew its position in Cardinal Health by 4,935.9% in the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after purchasing an additional 927,950 shares during the last quarter. Acadian Asset Management LLC increased its holdings in shares of Cardinal Health by 92.5% during the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock worth $282,063,000 after purchasing an additional 807,063 shares during the period. Prudential Financial Inc. raised its position in shares of Cardinal Health by 476.8% during the second quarter. Prudential Financial Inc. now owns 883,348 shares of the company’s stock valued at $148,402,000 after buying an additional 730,209 shares during the last quarter. Finally, Alyeska Investment Group L.P. acquired a new position in shares of Cardinal Health during the first quarter valued at about $92,219,000. 87.17% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on CAH. Deutsche Bank Aktiengesellschaft boosted their price target on Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research note on Tuesday, November 18th. UBS Group upped their target price on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research note on Friday, October 31st. Wells Fargo & Company lifted their price target on shares of Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. Mizuho boosted their price target on shares of Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a report on Monday, November 3rd. Finally, Robert W. Baird set a $232.00 price objective on shares of Cardinal Health in a report on Friday, October 31st. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $209.00.

Get Our Latest Stock Analysis on Cardinal Health

Cardinal Health Price Performance

Cardinal Health stock opened at $207.33 on Wednesday. The firm has a market capitalization of $49.26 billion, a P/E ratio of 31.27, a P/E/G ratio of 1.51 and a beta of 0.63. The stock has a fifty day moving average price of $198.26 and a two-hundred day moving average price of $170.92. Cardinal Health, Inc. has a 52-week low of $117.53 and a 52-week high of $214.93.

Cardinal Health (NYSE:CAHGet Free Report) last posted its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.33. The business had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The firm’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be issued a dividend of $0.5107 per share. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

About Cardinal Health

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Recommended Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.